Midas Pharma
 | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (September 2024) |
Midas Pharma is a German pharmaceutical company founded in 1988.[1] The company has 300 employees (as of 2023) and revenue of 550 million EUR (2023). Among other products,[2] it makes a biosimilar for ranibizumab under brand name Ranivisio, approved in 2022 by EMA.[3]
References
[edit]- ^ "History". www.midas-pharma.com. Retrieved 2024-09-04.
- ^ "Midas Pharma - discover our products". www.midas-pharma.com. Retrieved 2024-09-04.
- ^ "Ranivisio Authorization details". EMA.
External links
[edit]
 | This German corporation or company article is a stub. You can help Wikipedia by expanding it. |